Lilly: Medicare Covers Obesity Meds
Eli Lilly announces Medicare Part D patients may access Foundayo or Zepbound for weight management under the Medicare GLP-1 Bridge program for $50 per month starting July 1
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.